KR101314995B1 - 항치주병균제 및 그것을 사용한 의료용 또는 치과용 재료 - Google Patents
항치주병균제 및 그것을 사용한 의료용 또는 치과용 재료 Download PDFInfo
- Publication number
- KR101314995B1 KR101314995B1 KR1020117016671A KR20117016671A KR101314995B1 KR 101314995 B1 KR101314995 B1 KR 101314995B1 KR 1020117016671 A KR1020117016671 A KR 1020117016671A KR 20117016671 A KR20117016671 A KR 20117016671A KR 101314995 B1 KR101314995 B1 KR 101314995B1
- Authority
- KR
- South Korea
- Prior art keywords
- protamine
- dna
- medical
- complex
- dental material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
- A61K6/838—Phosphorus compounds, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dental Preparations (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Polymers & Plastics (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JPJP-P-2008-324524 | 2008-12-19 | ||
| JP2008324524 | 2008-12-19 | ||
| JP2009208631A JP4801193B2 (ja) | 2008-12-19 | 2009-09-09 | 骨形成用の医療用または歯科用材料 |
| JPJP-P-2009-208631 | 2009-09-09 | ||
| PCT/JP2009/071231 WO2010071217A1 (ja) | 2008-12-19 | 2009-12-21 | 抗歯周病菌剤及びそれを用いた医療用または歯科用材料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20110111412A KR20110111412A (ko) | 2011-10-11 |
| KR101314995B1 true KR101314995B1 (ko) | 2013-10-04 |
Family
ID=42268883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020117016671A Expired - Fee Related KR101314995B1 (ko) | 2008-12-19 | 2009-12-21 | 항치주병균제 및 그것을 사용한 의료용 또는 치과용 재료 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9486496B2 (enExample) |
| EP (1) | EP2377545A4 (enExample) |
| JP (1) | JP4801193B2 (enExample) |
| KR (1) | KR101314995B1 (enExample) |
| TW (1) | TWI400083B (enExample) |
| WO (1) | WO2010071217A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5467800B2 (ja) * | 2009-05-14 | 2014-04-09 | ロート製薬株式会社 | 唾液分泌促進剤及び唾液分泌促進用組成物 |
| US10166313B2 (en) | 2013-09-25 | 2019-01-01 | Maruha Nichiro Corporation | Medical or dental material for osteogenesis |
| DE112015004182T5 (de) * | 2014-09-12 | 2018-01-11 | Maruha Nichiro Corporation | Antimykotische Zusammensetzung umfassend antimykotisches Peptid und Terpenalkohol |
| CN108721135A (zh) * | 2017-04-21 | 2018-11-02 | 学校法人明治大学 | 具有牙本质小管封闭性的牙处置用材料 |
| CN114028606B (zh) * | 2021-10-26 | 2023-06-13 | 湘雅生物医药(湖州)有限公司 | 一种壳聚糖、鱼精蛋白抗菌止血微球及其制备方法 |
| WO2025110384A1 (ko) * | 2023-11-24 | 2025-05-30 | 정인선 | 항균성 및 중합깊이가 향상된 심미수복용 복합레진 및 항균 및 항바이러스성 3d 프린팅 의치상용 레진 조성물, 그리고 이들의 제조 방법 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001327591A (ja) * | 2000-03-13 | 2001-11-27 | Shigeo Okahata | 医療用または歯科用材料およびその製造方法 |
| JP2005289852A (ja) | 2004-03-31 | 2005-10-20 | Shigeo Okahata | 医療用材料および/または歯科用材料と、その製造方法。 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61115030A (ja) * | 1984-11-07 | 1986-06-02 | Lion Corp | 骨疾患治療剤 |
| JPH0755235B2 (ja) * | 1986-09-08 | 1995-06-14 | 新田ゼラチン株式会社 | 骨形成用注入材料 |
| JPS6434371A (en) * | 1987-07-31 | 1989-02-03 | Nitta Gelatin Kk | Periosteal bone forming material |
| JPH01202072A (ja) * | 1988-02-08 | 1989-08-15 | Toshiba Corp | ノイズリデューサ回路 |
| JPH01207072A (ja) * | 1988-02-15 | 1989-08-21 | Yasumasa Otori | 骨形成材料およびその製法 |
| JPH02241460A (ja) * | 1989-03-16 | 1990-09-26 | Asahi Optical Co Ltd | 骨修復用複合材料 |
| JPH08239398A (ja) | 1995-03-03 | 1996-09-17 | Sogo Yatsukou Kk | 水不溶性、自己支持性透明dna・脂質複合体フィルムおよびその製造方法 |
| JP3873429B2 (ja) | 1998-02-20 | 2007-01-24 | 大鵬薬品工業株式会社 | ペプチド誘導体及びその薬学的に許容される塩、その製造方法及びその用途 |
| JP2001089436A (ja) | 1999-09-20 | 2001-04-03 | Sagami Chem Res Center | アルギニン誘導体、アルギンギパイン阻害剤、及び抗歯周病剤 |
| JP2001321123A (ja) * | 2000-05-15 | 2001-11-20 | Takeshi Inoi | 抗う蝕性食品素材、およびその組成物 |
| JP2002060341A (ja) * | 2000-08-21 | 2002-02-26 | Terumo Corp | 止血剤 |
| US7204874B2 (en) * | 2001-10-24 | 2007-04-17 | Pentron Clinical Technologies, Llc | Root canal filling material |
| US7758892B1 (en) * | 2004-05-20 | 2010-07-20 | Boston Scientific Scimed, Inc. | Medical devices having multiple layers |
| US20080139450A1 (en) * | 2005-07-01 | 2008-06-12 | Srinivasa Madhyastha | Antimicrobial Compositions and Uses Thereof |
| AU2006265707B2 (en) | 2005-07-01 | 2012-06-14 | Kane Biotech Inc. | Antimicrobial compositions for inhibiting growth and proliferation of a microbial biofilm on medical devices |
| JP4354445B2 (ja) * | 2005-10-05 | 2009-10-28 | 恵雄 岡畑 | Dna/キトサン複合体の成形方法 |
| JP2007169201A (ja) | 2005-12-21 | 2007-07-05 | Lion Corp | 口腔用組成物 |
| JP4718416B2 (ja) * | 2006-10-31 | 2011-07-06 | 忠男 福島 | Dnaとポリカチオンの複合体からのフィルムの製造方法 |
| JP4520477B2 (ja) | 2006-10-31 | 2010-08-04 | 株式会社マルハニチロ食品 | 抗真菌ペプチドまたはそれを含有するペプチド組成物とその製造方法 |
-
2009
- 2009-09-09 JP JP2009208631A patent/JP4801193B2/ja not_active Expired - Fee Related
- 2009-12-21 TW TW098143881A patent/TWI400083B/zh not_active IP Right Cessation
- 2009-12-21 KR KR1020117016671A patent/KR101314995B1/ko not_active Expired - Fee Related
- 2009-12-21 WO PCT/JP2009/071231 patent/WO2010071217A1/ja not_active Ceased
- 2009-12-21 EP EP09833518.5A patent/EP2377545A4/en not_active Withdrawn
- 2009-12-21 US US13/140,931 patent/US9486496B2/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001327591A (ja) * | 2000-03-13 | 2001-11-27 | Shigeo Okahata | 医療用または歯科用材料およびその製造方法 |
| JP2005289852A (ja) | 2004-03-31 | 2005-10-20 | Shigeo Okahata | 医療用材料および/または歯科用材料と、その製造方法。 |
Non-Patent Citations (2)
| Title |
|---|
| Infect. Immun. 67(9): 4917-4920 (1999. 9.) * |
| J. Oral. Tissue Engin. 6(1): 24-32 (2008) * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010163421A (ja) | 2010-07-29 |
| EP2377545A4 (en) | 2015-05-27 |
| US20110257094A1 (en) | 2011-10-20 |
| US9486496B2 (en) | 2016-11-08 |
| JP4801193B2 (ja) | 2011-10-26 |
| EP2377545A1 (en) | 2011-10-19 |
| TWI400083B (zh) | 2013-07-01 |
| KR20110111412A (ko) | 2011-10-11 |
| TW201028172A (en) | 2010-08-01 |
| WO2010071217A1 (ja) | 2010-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Abbass et al. | Hydrogels and dentin–pulp complex regeneration: from the benchtop to clinical translation | |
| Pramanik et al. | Chitosan alchemy: transforming tissue engineering and wound healing | |
| Liu et al. | Preparation and applications of peptide-based injectable hydrogels | |
| Li et al. | Multifunctional smart hydrogels: Potential in tissue engineering and cancer therapy | |
| Li et al. | Porous chitosan bilayer membrane containing TGF-β1 loaded microspheres for pulp capping and reparative dentin formation in a dog model | |
| Ayala-Ham et al. | Hydrogel-based scaffolds in oral tissue engineering | |
| KR101314995B1 (ko) | 항치주병균제 및 그것을 사용한 의료용 또는 치과용 재료 | |
| US20090291114A1 (en) | Osteogenic composition comprising a growth factor/amphiphilic polymer complex, a soluble cation salt and an organic support | |
| Zhu et al. | Injectable hydrogels with ROS-triggered drug release enable the co-delivery of antibacterial agent and anti-inflammatory nanoparticle for periodontitis treatment | |
| US20220288273A1 (en) | Osteoinductive modified gelatin hydrogels and methods of making and using the same | |
| CN115947827A (zh) | 一种重组胶原蛋白及其在软骨修复基质中的用途 | |
| Vimalraj et al. | Tooth-derived stem cells integrated biomaterials for bone and dental tissue engineering | |
| Li et al. | BMP-2 plasmid DNA-loaded chitosan films–A new strategy for bone engineering | |
| Pilloni et al. | Hyaluronic acid: A novel approach in regenerative/reconstructive periodontal therapy? | |
| Tsuboi et al. | Development of a novel dental resin cement incorporating FGF-2-loaded polymer particles with the ability to promote tissue regeneration | |
| KR102048914B1 (ko) | 콘드로이틴설페이트가 함유된 젤란검 하이드로겔 조성물 | |
| CN101085357A (zh) | 一种用于关节腔内注射治疗软骨缺损的非病毒纳米核酸转运复合物及其制备方法 | |
| Balakrishnan et al. | Injectable hydrogels for biomedical applications | |
| Fan et al. | Biocompatible conjugation for biodegradable hydrogels as drug and cell scaffolds | |
| NL2007179C2 (en) | Chitosan-based hydrogels containing enzyme alkaline phosphatase. | |
| WO2021169075A1 (zh) | 一种集可注射与抗菌于一体的双功能水凝胶及其制备方法和用途 | |
| Bombaldi de Souza et al. | Xanthan Gum for Regenerative Medicine | |
| KR101918371B1 (ko) | 골 형성용의 의료용 또는 치과용 재료 | |
| Fereig et al. | Chitosan-based Hydrogels in Drug Delivery | |
| JP2005289852A (ja) | 医療用材料および/または歯科用材料と、その製造方法。 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| A201 | Request for examination | ||
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| FPAY | Annual fee payment |
Payment date: 20160824 Year of fee payment: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| FPAY | Annual fee payment |
Payment date: 20170808 Year of fee payment: 5 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| FPAY | Annual fee payment |
Payment date: 20180813 Year of fee payment: 6 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 6 |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20190928 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20190928 |